Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion
- PMID: 6342832
- DOI: 10.1161/01.res.52.5.515
Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion
Abstract
The efficacy of hyperglycemia and insulin therapy for reducing ischemic myocardial injury is controversial and unproven. Accordingly, factors that might influence the effects of hyperglycemia and insulin were studied in isolated perfused rabbit hearts at two degrees of global ischemia, either "severe" or "moderate." During the ischemic period, different groups (n = 15-28/group) received either 100 mg/100 ml glucose-no insulin (control group), 500 mg/100 ml glucose + 100 mU/ml insulin (G + I), or 100 mg/100 ml glucose + 400 mg/100 ml mannitol (osmotic control). During moderate ischemia, effective washout of myocardial lactate was maintained, and hyperglycemia and insulin doubled the glycolytic flux, completely prevented contracture during ischemia, decreased contracture during reperfusion, increased recovery of postischemic contractile function, decreased ultrastructural damage, and increased high energy phosphate levels. Hyperglycemia and insulin increased glycolytic flux only after 30 minutes of ischemia had elapsed, suggesting that endogenous glycogen provided adequate glycolytic substrate prior to this time. The mannitol-glucose substrate had no beneficial effects, indicating that the hyperglycemia and insulin substrate had a metabolic rather than an osmotic mechanism of action. In contrast, during severe ischemia, tissue lactate washout was ineffective; the hyperglycemia and insulin substrate increased glycolytic flux by only 15% and produced no persistent beneficial effects. These results suggest that hyperglycemia and insulin therapy is beneficial to the ischemic myocardium when two conditions are met. First, the degree of myocardial perfusion, although in the ischemic range, must be adequate to prevent the accumulation of high tissue levels of lactate which inhibit glycolysis and prevent any glycolytic stimulation by hyperglycemia and insulin. Second, the ischemic myocardium must be "glucose dependent" for glycolytic substrate; in our studies this occurred after 30-45 minutes of sustained ischemia, probably because myocardial glycogen stores became depleted.
Similar articles
-
The relative importance of myocardial energy metabolism compared with ischemic contracture in the determination of ischemic injury in isolated perfused rabbit hearts.Circ Res. 1994 May;74(5):817-28. doi: 10.1161/01.res.74.5.817. Circ Res. 1994. PMID: 8156629
-
Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved.Circ Res. 1996 Mar;78(3):482-91. doi: 10.1161/01.res.78.3.482. Circ Res. 1996. PMID: 8593707
-
Glucose requirement for postischemic recovery of perfused working heart.Eur J Biochem. 1990 Mar 10;188(2):481-93. doi: 10.1111/j.1432-1033.1990.tb15426.x. Eur J Biochem. 1990. PMID: 2318214
-
Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.Mol Cell Biochem. 1998 Mar;180(1-2):3-26. Mol Cell Biochem. 1998. PMID: 9546626 Review.
-
Metabolic derangement in ischemic heart disease and its therapeutic control.Am J Cardiol. 1998 Sep 3;82(5A):2K-13K. doi: 10.1016/s0002-9149(98)00531-1. Am J Cardiol. 1998. PMID: 9737480 Review.
Cited by
-
Myocardial ischemia--metabolic pathways and implications of increased glycolysis.Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 4:777-90. doi: 10.1007/BF00051275. Cardiovasc Drugs Ther. 1990. PMID: 1965525 Review.
-
Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.J Clin Invest. 1990 Oct;86(4):1222-33. doi: 10.1172/JCI114828. J Clin Invest. 1990. PMID: 2170448 Free PMC article.
-
The effect of insulin on the heart: Part 2: Effects on function during and post myocardial ischaemia.Neth Heart J. 2010 May;18(5):255-9. doi: 10.1007/BF03091772. Neth Heart J. 2010. PMID: 20505799 Free PMC article.
-
Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.Pharmacogenomics J. 2017 Jan;17(1):76-83. doi: 10.1038/tpj.2015.84. Epub 2015 Dec 8. Pharmacogenomics J. 2017. PMID: 26644202 Clinical Trial.
-
Glucose and insulin management in the post-MI setting.Curr Diab Rep. 2002 Feb;2(1):37-44. doi: 10.1007/s11892-002-0055-9. Curr Diab Rep. 2002. PMID: 12643121 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous